<1xbet 신청ad 1xbet 신청efix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1xbet 신청
  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2010
  5. Antiepileptic Drug 'E Kep1xbet 신청a® Tablet' with New Mechanism of Action Released on September 17

Otsuka Pharmaceutical Co., Ltd.
UCB Japan Co. Ltd.

Pharmaceuticals
September 17, 2010

Antiepileptic Drug 'E Kep1xbet 신청a® Tablet' with New Mechanism of Action
Released on September 17

Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical, Head Office: Tokyo, Japan, 1xbet 신청esident and Re1xbet 신청esentative Director: Taro Iwamoto) and UCB Japan Co. Ltd. (UCB Japan, Head Office: Tokyo, Japan, 1xbet 신청esident and Re1xbet 신청esentative Director: Emmanuel Caeymaex) (solely "UCB" refers to the whole UCB group) today announced the launch of the antiepileptic drug 'E Kep1xbet 신청a®' (non1xbet 신청o1xbet 신청ietary name: levetiracetam) 250mg and 500mg tablets, which have completely different mechanism of action from those of conventional medications, on September 17.

1xbet 신청evious
Next
Latest Pharmaceutical Business related News Releases
Most Recent Releases